Augmentin and Kadcyla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Kadcyla (ado-trastuzumab emtansine). Common drug interactions include headache among females and acetabulum fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Kadcyla. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Kadcyla?

Kadcyla has active ingredients of ado-trastuzumab emtansine. eHealthMe is studying from 5,813 Kadcyla users. Check the latest studies of Kadcyla.

On Jul, 13, 2026

13 people who take Augmentin and Kadcyla together, and have interactions are studied.

Augmentin and Kadcyla drug interactions.

What are the common drug interactions of Augmentin and Kadcyla, by gender? *:

female:

Headache (pain in head)
Vomiting
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
Vertigo
Pneumonia
Nausea (feeling of having an urge to vomit)
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Blindness
Bone pain

male:

Acetabulum fracture (socket of the hip joint- fracture)
Chest pain
Osteolysis (dissolution of bone)
Pathological fracture (broken bone caused by disease)
Pleural effusion (water on the lungs)
Spinal compression fracture (fracture due to spinal compression on bone)
Staphylococcus test positive
Wound haemorrhage (bleeding wound)
Constipation
Disease progression

What are the common drug interactions of Augmentin and Kadcyla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
Chest pain
Pneumonia
Acetabulum fracture (socket of the hip joint- fracture)
Constipation
Disease progression
Dyspnoea exertional (breathlessness or shortness of breath)
Enterococcus test positive
Fractured sacrum
Haemoglobin decreased

40-49:

n/a

50-59:

n/a

60+:

Headache (pain in head)
Vomiting
Diarrhoea
Epistaxis (bleed from the nose)
Myalgia (muscle pain)
Visual impairment
Pneumonia
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Conjunctivitis (pink eye)
Dyspnoea exertional (breathlessness or shortness of breath)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Abdominal Pain Upper: 4 people, 30.77%
Respiratory Tract Infection: 3 people, 23.08%
Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 23.08%
Back Pain: 3 people, 23.08%
Hepatic Pain (pain in liver): 3 people, 23.08%
Cataract (clouding of the lens inside the eye): 2 people, 15.38%
Fainting (loss of consciousness and postural tone): 2 people, 15.38%
Constipation: 2 people, 15.38%
Chills (felling of cold): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Kadcyla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously